(Q45183209)

English

Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma

scientific article published in December 2004

Statements

Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit